PTK2 and cancer: In many cancers, FAK pathway overexpression has been linked to more aggressive tumour behaviour, in particularly in regards to the promotion of tumour cell proliferation, survival, motility, invasion, stem cell renewal, angiogenesis, and metastasis [3,4,5].